CD8A and neoplasm: The process includes recognition of local antigens by dendritic cells (DC), migration to regional lymph nodes, where they present processed tumor-derived peptides to naïve CD8+ and CD4+ T cells, which leave afterwards lymphoid organs to infiltrate tumor tissues and exert effector functions, killing tumor cells.